default author photo

Clare Turnbull

Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology

London

United Kingdom

SCHOLARLY PAPERS

5

DOWNLOADS

531

TOTAL CITATIONS

7

Scholarly Papers (5)

1.

Collateral Damage: The Impact on Cancer Outcomes of the COVID-19 Pandemic

Number of pages: 29 Posted: 20 May 2020
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Public Health England - National Cancer Registration and Analysis Service, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Royal Marsden NHS Foundation Trust - Urology Unit, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust - Department of Colorectal Surgery, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Royal Marsden NHS Foundation Trust - Lung Cancer Unit, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Royal Marsden NHS Foundation Trust - Department of Clinical Oncology, Royal Marsden NHS Foundation Trust - RM Partners, University of Cambridge - Department of Public Health and Primary Care, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Imperial College Healthcare NHS Trust - Department of Clinical Oncology, Public Health England - National Cancer Registration and Analysis Service, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 172 (440,151)
Citation 6

Abstract:

Loading...

cancer; diagnosis; surgery; COVID-19 pandemic; diagnostic delay; healthcare resource; life years gained; survival

2.

Risks of Second Primary Cancers for Female and Male Breast Cancer Survivors in England: A Retrospective Cohort Study

Number of pages: 53 Posted: 16 Jan 2024
University of Cambridge, University of Cambridge, University of Cambridge, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Government of the United Kingdom - National Health Service (NHS), Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), University of Southampton, University of Oxford, Government of the United Kingdom - National Health Service (NHS), Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, University of Cambridge, Cedars-Sinai Medical Center and University of Cambridge
Downloads 109 (659,652)
Citation 1

Abstract:

Loading...

Breast Cancer, Second Primary Cancer, Risk, Incidence, Treatment, Pathology, Deprivation, Epidemiology

3.

Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022

Number of pages: 26 Posted: 02 Oct 2025
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, University of Cambridge, University of Cambridge, University of Cambridge, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Imperial College London, The University of Manchester - Manchester University NHS Foundation Trust, affiliation not provided to SSRN, Newcastle University, University of Oxford, University of Cambridge, University of Cambridge - Centre for Cancer Genetic Epidemiology, Cedars-Sinai Medical Center, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS) and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 96 (725,554)

Abstract:

Loading...

Lynch syndrome, genetics, epidemiology, surveillance, big data, public health, colonoscopy, colorectal cancer, screening

4.

Limitations of Polygenic Risk Scores for Stratified Cancer Screening: A UK Modelling Study

Number of pages: 24 Posted: 24 Feb 2023
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, St George’s University London, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Government of the United Kingdom - National Cancer Registration and Analysis Service, University of Southampton - Clinical Ethics and Law, University of St Andrews - Population and Behavioural Science Division, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 80 (823,616)

Abstract:

Loading...

5.

Quantifying and Mitigating the Impact of the COVID-19 Pandemic on Outcomes in Colorectal Cancer

Number of pages: 25 Posted: 08 Jun 2020
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Public Health England - National Cancer Registration and Analysis Service, West London Cancer Alliance - RM Partners, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Royal Marsden NHS Foundation Trust - Urology Unit, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust - Department of Colorectal Surgery, Imperial College Healthcare NHS Trust - Department of Clinical Oncology, Public Health England - National Cancer Registration and Analysis Service, West London Cancer Alliance - RM Partners, Imperial College London - School of Public Health, West London Cancer Alliance - RM Partners, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Imperial College London - School of Public Health, NHS Foundation Trust - Croydon University Hospital, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 74 (852,604)

Abstract:

Loading...

COVID-19; Oncology; Colonoscopy; Endoscopy; Fecal Immunochemical Test; FIT; Bowel; Colorectal; Cancer; Pandemic; delay in treatment